On April 9th, the Announcement on Supplementary Filing of High tech Enterprises Recognized and Reported by Jiangsu Provincial Certification Institutions in 2023 was announced, and Nanjing Regenecore Biotechnology Co., Ltd. was approved for the re examination of the recognition of high-tech enterprises. In December 2020, Regenecore was first recognized as a national high-tech enterprise.

Regenecore focuses on technological innovation and is committed to developing new technologies and products. The policy support after the approval of high-tech enterprises helps to stimulate their enthusiasm for independent innovation, improve their technological innovation capabilities, introduce high-tech talents, provide a good development environment and opportunities for enterprises, and promote technological innovation and achievement transformation.

The approval of the reexamination of Regenecore High tech Enterprise proves that the company's development and technical capabilities have been recognized. It is a nationally supported enterprise with high growth potential and has good potential economic benefits, which more effectively proves that Regenecore has strong technological innovation and high-end technology development capabilities in the field of pharmaceutical research and development.